array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Tekla Life Sciences Investors"
["slug"]=>
string(38) "30be8-us-tekla-life-sciences-investors"
["logo"]=>
NULL
["description"]=>
string(523) "Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL."
["address_street"]=>
string(17) "2 Liberty Sq FL 9"
["address_place"]=>
string(6) "Boston"
["address_region"]=>
string(13) "Massachusetts"
["founding_date"]=>
string(10) "2000-01-26"
["website_domain"]=>
string(12) "teklacap.com"
["website_url"]=>
string(24) "https://www.teklacap.com"
["industry_codes"]=>
array(1) {
[0]=>
string(39) "Management Investment Offices, Open-End"
}
["employee_count"]=>
int(7)
["article_count"]=>
int(78)
}
["articles"]=>
array(6) {
[0]=>
array(7) {
["title_en"]=>
string(59) "Tekla Life Sciences Investors Paid Distribution | Tekla ..."
["snippet_en"]=>
string(250) "30-06-2021 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon"
["url"]=>
string(79) "https://www.teklacap.com/news/tekla-life-sciences-investors-paid-distribution4/"
["image_url"]=>
NULL
["source"]=>
string(12) "teklacap.com"
["publication_date"]=>
string(10) "2021-06-30"
["categories"]=>
array(1) {
[0]=>
string(10) "Tax Havens"
}
}
[1]=>
array(7) {
["title_en"]=>
string(59) "Tekla Life Sciences Investors Paid Distribution | Tekla ..."
["snippet_en"]=>
string(250) "31-03-2021 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon"
["url"]=>
string(85) "https://www.teklacap.com/news/tekla-life-sciences-investors-paid-distribution-033121/"
["image_url"]=>
NULL
["source"]=>
string(12) "teklacap.com"
["publication_date"]=>
string(10) "2021-03-31"
["categories"]=>
array(1) {
[0]=>
string(10) "Tax Havens"
}
}
[2]=>
array(7) {
["title_en"]=>
string(59) "Tekla Life Sciences Investors Pays Distribution | Tekla ..."
["snippet_en"]=>
string(250) "30-09-2016 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon"
["url"]=>
string(82) "https://www.teklacap.com/news/tekla-healthcare-investors-pays-distribution-21-2-2/"
["image_url"]=>
NULL
["source"]=>
string(12) "teklacap.com"
["publication_date"]=>
string(10) "2021-02-02"
["categories"]=>
array(1) {
[0]=>
string(10) "Tax Havens"
}
}
[3]=>
array(7) {
["title_en"]=>
string(59) "Tekla Life Sciences Investors Paid Distribution | Tekla ..."
["snippet_en"]=>
string(250) "31-12-2018 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon"
["url"]=>
string(85) "https://www.teklacap.com/news/tekla-life-sciences-investors-paid-distribution-123118/"
["image_url"]=>
NULL
["source"]=>
string(12) "teklacap.com"
["publication_date"]=>
string(10) "2018-12-31"
["categories"]=>
array(1) {
[0]=>
string(10) "Tax Havens"
}
}
[4]=>
array(7) {
["title_en"]=>
string(59) "Tekla Life Sciences Investors Paid Distribution | Tekla ..."
["snippet_en"]=>
string(250) "29-06-2018 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon"
["url"]=>
string(85) "https://www.teklacap.com/news/tekla-life-sciences-investors-paid-distribution-062818/"
["image_url"]=>
NULL
["source"]=>
string(12) "teklacap.com"
["publication_date"]=>
string(10) "2018-06-29"
["categories"]=>
array(1) {
[0]=>
string(10) "Tax Havens"
}
}
[5]=>
array(7) {
["title_en"]=>
string(59) "Tekla Life Sciences Investors Paid Distribution | Tekla ..."
["snippet_en"]=>
string(249) "The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’ s"
["url"]=>
string(78) "https://www.teklacap.com/news/tekla-life-sciences-investors-paid-distribution/"
["image_url"]=>
NULL
["source"]=>
string(12) "teklacap.com"
["publication_date"]=>
string(10) "2016-08-12"
["categories"]=>
array(1) {
[0]=>
string(10) "Tax Havens"
}
}
}
["category_annotations"]=>
array(22) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(16)
}
[1]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[2]=>
array(2) {
["name"]=>
string(10) "Tax Havens"
["count"]=>
int(6)
}
[3]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(5)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(4)
}
[5]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(4)
}
[6]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(3)
}
[9]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(2)
}
[10]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(2)
}
[11]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(2)
}
[12]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(2)
}
[13]=>
array(2) {
["name"]=>
string(22) "Business Restructuring"
["count"]=>
int(2)
}
[14]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(1)
}
[16]=>
array(2) {
["name"]=>
string(23) "Supply Chain Management"
["count"]=>
int(1)
}
[17]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(1)
}
[18]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(1)
}
[19]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(1)
}
[20]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(1)
}
[21]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(1)
}
}
}
30be8-us-tekla-life-sciences-investors
Tekla Life Sciences Investors
Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
https://www.teklacap.com
Articles
78 Articles
Category
Management Investment Offices, Open-End
Description
Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL.
30-06-2021 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon
31-03-2021 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon
30-09-2016 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon
31-12-2018 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon
29-06-2018 · The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon
The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’ s
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
